tirzepatide cardiovascular outcomes trial results july 2025 In patients with type 2 diabetes and atherosclerotic disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT results: https://nej.md/4qd5rLx Effects of Tirzepatide on the
Description
Long-term use depends on clinical response and medical assessment
Ongoing research continues to refine comparative safety data
M., et al., Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity, Circulation 151, no
By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease
Frequently Asked Questions No latex is listed in Zepbounds components
